INTC
43
6
SNA
52
2
L
71
2
C
82
3
PM
49
2
BAX
38
-12
AN
50
7
MS
74
5
AVB
34
-3
MLM
67
4
HAL
50
2
CFG
95
2
UNP
38
2
WFC
74
5
PBI
68
2
GOOG
57
2
PFE
33
-8
CMCSA
44
-2
ILMN
73
4
PH
62
2
INTC
43
6
SNA
52
2
L
71
2
C
82
3
PM
49
2
BAX
38
-12
AN
50
7
MS
74
5
AVB
34
-3
MLM
67
4
HAL
50
2
CFG
95
2
UNP
38
2
WFC
74
5
PBI
68
2
GOOG
57
2
PFE
33
-8
CMCSA
44
-2
ILMN
73
4
PH
62
2
Financhill
Back

Invesco Bloomberg Analyst Rating Improvers ETF Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison

Buy
67

UPGD
Invesco Bloomberg Analyst Rating Improvers ETF

Last Price:
$74.96
Seasonality Move:
5.42%
Buy
54

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:
$59.30
Seasonality Move:
5.52%
Buy
67
Invesco Bloomberg Analyst Rating Improvers ETF (UPGD) is a Buy

Is Invesco Bloomberg Analyst Rating Improvers ETF a Buy, Sell or Hold?

  • The current Invesco Bloomberg Analyst Rating Improvers ETF [UPGD] share price is $76.06. The Score for UPGD is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • UPGD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN) is a Buy

Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UPGD Stock Price Chart

What is Invesco Bloomberg Analyst Rating Improvers ETF's stock price today?

  • The Invesco Bloomberg Analyst Rating Improvers ETF share price today is $76.06
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UPGD is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Stock Price Chart

What is BioMarin Pharmaceutical, Inc.'s stock price today?

  • The BioMarin Pharmaceutical, Inc. share price today is $61.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.

UPGD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 14.28 Buy
Relative Strength Index (14 RSI): 61.37 Buy
Chaikin Money Flow: 474 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.73 - 75.99) Buy
Bollinger Bands (100): (73.01 - 75.39) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 73.39 Buy
Chaikin Money Flow: 7836963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.19 - 56.01) Buy
Bollinger Bands (100): (52.65 - 57.43) Buy

UPGD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 76.02 Buy
20-day SMA: 75.03 Buy
50-day SMA: 74.17 Buy
200-day SMA: 71.95 Buy
8-day EMA: 40.21 Buy
20-day EMA: 19.69 Buy
50-day EMA: 8.59 Buy
200-day EMA: 2.24 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.6 Buy
20-day SMA: 54.21 Buy
50-day SMA: 53.61 Buy
200-day SMA: 57.94 Buy
8-day EMA: 54.44 Buy
20-day EMA: 53.99 Buy
50-day EMA: 54.1 Buy
200-day EMA: 58.28 Buy

Invesco Bloomberg Analyst Rating Improvers ETF Earnings Growth & UPGD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.73 per share.

Invesco Bloomberg Analyst Rating Improvers ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioMarin Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):